|
|
|
|
|
|
|
|
|
|
Turn multiomics data into smarter drug discovery decisions. Join leading biopharma experts on October 27, 2026, at 11 AM ET to explore how genomics, transcriptomics, proteomics, metabolomics, spatial biology, and AI are being integrated to identify targets, validate mechanisms, and prioritize programs. Hear real-world examples and practical lessons for making multiomics a powerful driver of R&D productivity. Register today!
|
|
|
|
|
|
|
|
By Ray Dogum, Chief Editor, Drug Discovery Online
|
At the Datapoints Summit, speakers showed where AI can improve drug discovery—and why better data, validation, and scientific judgment remain essential for lasting progress.
|
|
|
|
|
|
Pharmacogenomics In Oncology: A Pharmacokinetic Perspective
|
|
By Anuli Khairatkar
|
The outcome of a medical treatment is not solely determined by the efficacy of the drug itself. It also depends on the patient’s genetic makeup, biological characteristics of the disease, and individual clinical factors.
|
|
|
|
|
|
|
|
|
|
Characterization Of Tumor-Specific T-Cells With Modifications
|
|
Poster | By James Goward, Nathalie Labarriere, Tiffany Beauvais, et al., QIAGEN
|
Explore a scalable RNA-seq approach that delivers reproducible, high-quality transcriptomic data from checkpoint-edited T-cells, uncovering gene expression changes linked to PD-1 and TIGIT deletion.
|
|
|
|
|
|
|
|
Chemoenzymatic N-glycan Conjugation Of Native mAbs
|
|
White Paper | By Remon van Geel, Marloes A. Wijdeven, Ryan Heesbeen, et al., Lonza
|
A chemoenzymatic two-stage protocol enables DAR2 ADCs from native mAbs via glycan remodeling at Asn-297 and copper-free click chemistry, with in vivo efficacy outperforming a comparable ADC.
|
|
|
|
|
|
|
|
Particle Engineering For Inhalation Drug Delivery
|
|
Application Note | By Matthew Ferguson, Lonza
|
Examine key parameters for choosing the right particle engineering approach to meet dry powder inhaler (DPI) target product profiles for inhalation-based drug products.
|
|
|
|
|
|
|
|
|
|
|
The Advanced Therapies Congress USA is America's largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. Join us in Boston for 2026! Use code LSC20 for 20% off. Book your ticket now
|
|
|
|
|
|
|
|
|
